| Src: coordinating metabolism in cancer SG Pelaz, A Tabernero Oncogene 41 (45), 4917-4928, 2022 | 56 | 2022 |
| Connexin43 peptide, TAT-Cx43266–283, selectively targets glioma cells, impairs malignant growth, and enhances survival in mouse models in vivo M Jaraíz-Rodríguez, R Talaverón, L García-Vicente, SG Pelaz, ... Neuro-oncology 22 (4), 493-504, 2020 | 50 | 2020 |
| Targeting metabolic plasticity in glioma stem cells in vitro and in vivo through specific inhibition of c-Src by TAT-Cx43266-283 SG Pelaz, M Jaraíz-Rodríguez, A Álvarez-Vázquez, R Talaverón, ... EBioMedicine 62, 2020 | 31 | 2020 |
| Impairment of Autophagic Flux Participates in the Antitumor Effects of TAT-Cx43266-283 in Glioblastoma Stem Cells SG Pelaz, C Ollauri-Ibáñez, C Lillo, A Tabernero Cancers 13 (17), 4262, 2021 | 12 | 2021 |
| Identification of potassium channel proteins Kv7. 2/7.3 as common partners of the dopamine and glutamate transporters DAT and GLT-1 D Bartolomé-Martín, I Ibáñez, D Piniella, E Martínez-Blanco, SG Pelaz, ... Neuropharmacology 161, 107568, 2019 | 10 | 2019 |
| Erratum to ‘Connexin43 peptide, TAT-Cx43266–283, selectively targets glioma cells, impairs malignant growth, and enhances survival in mouse models in vivo’ M Jaraíz-Rodríguez, R Talaverón, L García-Vicente, SG Pelaz, ... Neuro-oncology 23 (8), 1414-1414, 2021 | 2 | 2021 |
| A proteomic approach supports the clinical relevance of TAT-Cx43266-283 in glioblastoma SG Pelaz, R Flores-Hernández, T Vujic, D Schvartz, A Álvarez-Vázquez, ... Translational Research, 2024 | | 2024 |
| Targeting metabolic plasticity in glioma stem cells in vitro and in vivo through specific inhibition of c-Src by TAT-Cx43 (266-283)(vol 62, 103134, 2020) SG Pelaz, M Jaraiz-Rodriguez, A Alvarez-Vazquez, R Talaveron, ... EBIOMEDICINE 74, 2021 | | 2021 |
| Erratum to “Targeting metabolic plasticity in glioma stem cells in vitro and in vivo through specific inhibition of c-Src by TAT-Cx43266-283”[EBioMedicine 62, December 2020 SG Pelaz, M Jaraíz-Rodríguez, A Álvarez-Vázquez, R Talaverón, ... EBioMedicine 74, 2021 | | 2021 |
| Impairment of Autophagic Flux Participates in the Antitumor Effects of TAT-Cx43266-283 in Glioblastoma Stem Cells S Gutiérrez Pelaz, C Ollauri-Ibáñez, MC Lillo Delgado, A Tabernero | | 2021 |
| Efecto del péptido antitumoral TAT-Cx43266-283 en células madre neurales en un modelo de glioma in vivo AÁ Vázquez, RT Aguilocho, LG Vicente, SG Pelaz, RF Hernández, ... VII Jornadas de investigadoras de Castilla y León [Recurso electrónico]: la …, 2021 | | 2021 |
| Péptidos penetrantes para atacar al glioma y su microambiente LG Vicente, RT Aguilocho, MJ Rodríguez, AÁ Vázquez, RF Hernández, ... VII Jornadas de investigadoras de Castilla y León [Recurso electrónico]: la …, 2021 | | 2021 |
| Mediators of the anti-tumoral activity of TAT-Cx43266-283 in human glioblastoma stem cells SG Pelaz Universidad de Salamanca, 2021 | | 2021 |
| ACx43 peptide inhibits metabolic plasticity in human glioma stem cells while sparing human neural stem cells and astrocytes SG Pelaz, M Jaraíz-Rodríguez, A Álvarez-Vázquez, R Talaverón, ... ACx43 peptide inhibits metabolic plasticity in human glioma stem cells while …, 2021 | | 2021 |
| TAT-Cx43266-283 impairs metabolic plasticity in glioma stem cells in vitro and in vivo SG Pelaz, M Jaraíz-Rodríguez, R Talaverón, L García-Vicente, ... bioRxiv, 858563, 2019 | | 2019 |
| Reactive astrocytes in glioma models: Effect of cell-penetrating peptides based on connexin43 AT L García-Vicente, M Jaraíz-Rodríguez, SG Pelaz, JM Medina GLIA 67 (S1), E718, 2019 | | 2019 |
| Glucose metabolism in astrocytes and glioma stem cells: Effects of a peptide based on connexin43 AT S.G. Pelaz, M. Gómez de Cedrón, M. Tabernero, A. Ramírez de Molina, J.M ... GLIA 67 (S1), E719-E720, 2019 | | 2019 |
| Connexin43 peptide, TAT-Cx43 M Jaraíz-Rodríguez, R Talaverón, L García-Vicente, SG Pelaz, ... | | 2019 |
| PO-438 Internalisation of cell-penetrating peptides based on CONNEXIN43 in glioma stem cells and neural cells L García-Vicente, SG Pelaz, JM Medina, A Tabernero ESMO Open 3, A194, 2018 | | 2018 |
| PO-252 Impaired glucose metabolism in human glioma stem cells upon treatment with a cell-penetrating peptide based on CONNEXIN43 SG Pelaz, MG de Cedrón, M Tabernero, AR de Molina, JM Medina, ... ESMO Open 3, A119, 2018 | | 2018 |
Arantxa TaberneroInstituto de Neurociencias de Castilla y León (INCYL). Universidad de SalamancaΗ διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα usal.es
